HEADER OXIDOREDUCTASE 12-FEB-01 1I2Z TITLE E. COLI ENOYL REDUCTASE IN COMPLEX WITH NAD AND BRL-12654 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADH]; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ENOYL-ACP REDUCTASE; COMPND 5 EC: 1.3.1.9; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 562; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ENOYL REDUCTASE, NAD, ANTIBIOTIC, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR D.A.HEERDING,W.H.MILLER,D.J.PAYNE,C.A.JANSON,X.QIU REVDAT 5 07-FEB-24 1I2Z 1 REMARK REVDAT 4 03-OCT-18 1I2Z 1 REMARK REVDAT 3 13-JUL-11 1I2Z 1 VERSN REVDAT 2 24-FEB-09 1I2Z 1 VERSN REVDAT 1 12-FEB-02 1I2Z 0 JRNL AUTH D.A.HEERDING,G.CHAN,W.E.DEWOLF,A.P.FOSBERRY,C.A.JANSON, JRNL AUTH 2 D.D.JAWORSKI,E.MCMANUS,W.H.MILLER,T.D.MOORE,D.J.PAYNE,X.QIU, JRNL AUTH 3 S.F.RITTENHOUSE,C.SLATER-RADOSTI,W.SMITH,D.T.TAKATA, JRNL AUTH 4 K.S.VAIDYA,C.C.YUAN,W.F.HUFFMAN JRNL TITL 1,4-DISUBSTITUTED IMIDAZOLES ARE POTENTIAL ANTIBACTERIAL JRNL TITL 2 AGENTS FUNCTIONING AS INHIBITORS OF ENOYL ACYL CARRIER JRNL TITL 3 PROTEIN REDUCTASE (FABI). JRNL REF BIOORG.MED.CHEM.LETT. V. 11 2061 2001 JRNL REFN ISSN 0960-894X JRNL PMID 11514139 JRNL DOI 10.1016/S0960-894X(01)00404-8 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 7.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 12968 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : 5% REMARK 3 R VALUE (WORKING SET) : 0.191 REMARK 3 FREE R VALUE : 0.273 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 649 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3804 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 124 REMARK 3 SOLVENT ATOMS : 113 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.012 REMARK 3 BOND ANGLES (DEGREES) : 2.100 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1I2Z COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-FEB-01. REMARK 100 THE DEPOSITION ID IS D_1000012838. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JUN-99 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 106190 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.0 REMARK 200 DATA REDUNDANCY : 7.000 REMARK 200 R MERGE (I) : 0.06400 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 15.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 82.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.00 REMARK 200 R MERGE FOR SHELL (I) : 0.11700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.56 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.65 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 7555 Y,X,-Z+1/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+2/3 REMARK 290 10555 -Y,-X,-Z+5/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 107.79667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 215.59333 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 161.69500 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 269.49167 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 53.89833 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 107.79667 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 215.59333 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 269.49167 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 161.69500 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 53.89833 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 22110 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 29600 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -121.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.500000 -0.866025 0.000000 39.79000 REMARK 350 BIOMT2 2 -0.866025 -0.500000 0.000000 68.91830 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 269.49167 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 LEU A 259 REMARK 465 GLU A 260 REMARK 465 LEU A 261 REMARK 465 LYS A 262 REMARK 465 MET B 1001 REMARK 465 LEU B 1259 REMARK 465 GLU B 1260 REMARK 465 LEU B 1261 REMARK 465 LYS B 1262 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 204 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 205 CG CD CE NZ REMARK 470 ARG B1204 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 65 -0.75 -57.44 REMARK 500 PHE A 94 149.20 -170.42 REMARK 500 ASN A 155 -18.28 71.64 REMARK 500 ASN A 157 -128.54 40.07 REMARK 500 ASP A 202 67.59 35.61 REMARK 500 VAL B1065 -1.89 -55.90 REMARK 500 SER B1091 56.12 -109.06 REMARK 500 LEU B1100 33.12 -94.51 REMARK 500 ASP B1103 114.53 -35.14 REMARK 500 SER B1145 -167.96 -126.63 REMARK 500 ASN B1155 -23.96 74.29 REMARK 500 ASN B1157 -129.86 43.43 REMARK 500 VAL B1247 74.81 -112.83 REMARK 500 ASN B1257 25.30 -77.97 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR B1146 0.08 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 654 A 502 REMARK 615 654 B 1502 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 654 A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD B 1501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 654 B 1502 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1C14 RELATED DB: PDB REMARK 900 1C14 IS CRYSTAL STRUCTURE OF E. COLI ENOYL REDUCTASE-NAD+-TRICLOSAN REMARK 900 COMPLEX REMARK 900 RELATED ID: 1I30 RELATED DB: PDB REMARK 900 1I30 IS E. COLI ENOYL REDUCTASE +NAD+SB385826 DBREF 1I2Z A 1 262 UNP P29132 FABI_ECOLI 0 261 DBREF 1I2Z B 1001 1262 UNP P29132 FABI_ECOLI 0 261 SEQRES 1 A 262 MET GLY PHE LEU SER GLY LYS ARG ILE LEU VAL THR GLY SEQRES 2 A 262 VAL ALA SER LYS LEU SER ILE ALA TYR GLY ILE ALA GLN SEQRES 3 A 262 ALA MET HIS ARG GLU GLY ALA GLU LEU ALA PHE THR TYR SEQRES 4 A 262 GLN ASN ASP LYS LEU LYS GLY ARG VAL GLU GLU PHE ALA SEQRES 5 A 262 ALA GLN LEU GLY SER ASP ILE VAL LEU GLN CYS ASP VAL SEQRES 6 A 262 ALA GLU ASP ALA SER ILE ASP THR MET PHE ALA GLU LEU SEQRES 7 A 262 GLY LYS VAL TRP PRO LYS PHE ASP GLY PHE VAL HIS SER SEQRES 8 A 262 ILE GLY PHE ALA PRO GLY ASP GLN LEU ASP GLY ASP TYR SEQRES 9 A 262 VAL ASN ALA VAL THR ARG GLU GLY PHE LYS ILE ALA HIS SEQRES 10 A 262 ASP ILE SER SER TYR SER PHE VAL ALA MET ALA LYS ALA SEQRES 11 A 262 CYS ARG SER MET LEU ASN PRO GLY SER ALA LEU LEU THR SEQRES 12 A 262 LEU SER TYR LEU GLY ALA GLU ARG ALA ILE PRO ASN TYR SEQRES 13 A 262 ASN VAL MET GLY LEU ALA LYS ALA SER LEU GLU ALA ASN SEQRES 14 A 262 VAL ARG TYR MET ALA ASN ALA MET GLY PRO GLU GLY VAL SEQRES 15 A 262 ARG VAL ASN ALA ILE SER ALA GLY PRO ILE ARG THR LEU SEQRES 16 A 262 ALA ALA SER GLY ILE LYS ASP PHE ARG LYS MET LEU ALA SEQRES 17 A 262 HIS CYS GLU ALA VAL THR PRO ILE ARG ARG THR VAL THR SEQRES 18 A 262 ILE GLU ASP VAL GLY ASN SER ALA ALA PHE LEU CYS SER SEQRES 19 A 262 ASP LEU SER ALA GLY ILE SER GLY GLU VAL VAL HIS VAL SEQRES 20 A 262 ASP GLY GLY PHE SER ILE ALA ALA MET ASN GLU LEU GLU SEQRES 21 A 262 LEU LYS SEQRES 1 B 262 MET GLY PHE LEU SER GLY LYS ARG ILE LEU VAL THR GLY SEQRES 2 B 262 VAL ALA SER LYS LEU SER ILE ALA TYR GLY ILE ALA GLN SEQRES 3 B 262 ALA MET HIS ARG GLU GLY ALA GLU LEU ALA PHE THR TYR SEQRES 4 B 262 GLN ASN ASP LYS LEU LYS GLY ARG VAL GLU GLU PHE ALA SEQRES 5 B 262 ALA GLN LEU GLY SER ASP ILE VAL LEU GLN CYS ASP VAL SEQRES 6 B 262 ALA GLU ASP ALA SER ILE ASP THR MET PHE ALA GLU LEU SEQRES 7 B 262 GLY LYS VAL TRP PRO LYS PHE ASP GLY PHE VAL HIS SER SEQRES 8 B 262 ILE GLY PHE ALA PRO GLY ASP GLN LEU ASP GLY ASP TYR SEQRES 9 B 262 VAL ASN ALA VAL THR ARG GLU GLY PHE LYS ILE ALA HIS SEQRES 10 B 262 ASP ILE SER SER TYR SER PHE VAL ALA MET ALA LYS ALA SEQRES 11 B 262 CYS ARG SER MET LEU ASN PRO GLY SER ALA LEU LEU THR SEQRES 12 B 262 LEU SER TYR LEU GLY ALA GLU ARG ALA ILE PRO ASN TYR SEQRES 13 B 262 ASN VAL MET GLY LEU ALA LYS ALA SER LEU GLU ALA ASN SEQRES 14 B 262 VAL ARG TYR MET ALA ASN ALA MET GLY PRO GLU GLY VAL SEQRES 15 B 262 ARG VAL ASN ALA ILE SER ALA GLY PRO ILE ARG THR LEU SEQRES 16 B 262 ALA ALA SER GLY ILE LYS ASP PHE ARG LYS MET LEU ALA SEQRES 17 B 262 HIS CYS GLU ALA VAL THR PRO ILE ARG ARG THR VAL THR SEQRES 18 B 262 ILE GLU ASP VAL GLY ASN SER ALA ALA PHE LEU CYS SER SEQRES 19 B 262 ASP LEU SER ALA GLY ILE SER GLY GLU VAL VAL HIS VAL SEQRES 20 B 262 ASP GLY GLY PHE SER ILE ALA ALA MET ASN GLU LEU GLU SEQRES 21 B 262 LEU LYS HET NAD A 501 44 HET 654 A 502 18 HET NAD B1501 44 HET 654 B1502 18 HETNAM NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM 654 4-(2-THIENYL)-1-(4-METHYLBENZYL)-1H-IMIDAZOLE FORMUL 3 NAD 2(C21 H27 N7 O14 P2) FORMUL 4 654 2(C15 H14 N2 S) FORMUL 7 HOH *113(H2 O) HELIX 1 1 SER A 19 GLU A 31 1 13 HELIX 2 2 ASN A 41 LYS A 43 5 3 HELIX 3 3 LEU A 44 LEU A 55 1 12 HELIX 4 4 GLU A 67 TRP A 82 1 16 HELIX 5 5 PRO A 96 ASP A 101 5 6 HELIX 6 6 ASP A 103 VAL A 108 1 6 HELIX 7 7 THR A 109 SER A 121 1 13 HELIX 8 8 SER A 121 ARG A 132 1 12 HELIX 9 9 TYR A 146 GLU A 150 5 5 HELIX 10 10 ASN A 157 GLY A 178 1 22 HELIX 11 11 ASP A 202 THR A 214 1 13 HELIX 12 12 THR A 221 CYS A 233 1 13 HELIX 13 13 SER A 234 ALA A 238 5 5 HELIX 14 14 GLY A 250 ALA A 254 5 5 HELIX 15 15 SER B 1019 GLU B 1031 1 13 HELIX 16 16 ASN B 1041 LEU B 1055 1 15 HELIX 17 17 GLU B 1067 LYS B 1080 1 14 HELIX 18 18 PRO B 1096 ASP B 1101 5 6 HELIX 19 19 ASP B 1103 VAL B 1108 1 6 HELIX 20 20 THR B 1109 SER B 1121 1 13 HELIX 21 21 SER B 1121 ARG B 1132 1 12 HELIX 22 22 TYR B 1146 GLU B 1150 5 5 HELIX 23 23 ASN B 1157 GLY B 1178 1 22 HELIX 24 24 PRO B 1179 GLY B 1181 5 3 HELIX 25 25 THR B 1194 SER B 1198 5 5 HELIX 26 26 ASP B 1202 THR B 1214 1 13 HELIX 27 27 THR B 1221 CYS B 1233 1 13 HELIX 28 28 SER B 1234 ALA B 1238 5 5 HELIX 29 29 GLY B 1250 ALA B 1254 5 5 SHEET 1 A 7 VAL A 60 GLN A 62 0 SHEET 2 A 7 GLU A 34 TYR A 39 1 O PHE A 37 N LEU A 61 SHEET 3 A 7 ARG A 8 VAL A 11 1 N ILE A 9 O GLU A 34 SHEET 4 A 7 PHE A 85 HIS A 90 1 N ASP A 86 O ARG A 8 SHEET 5 A 7 LEU A 135 SER A 145 1 N ASN A 136 O PHE A 85 SHEET 6 A 7 VAL A 182 ALA A 189 1 O ARG A 183 N LEU A 141 SHEET 7 A 7 VAL A 244 VAL A 247 1 O VAL A 245 N SER A 188 SHEET 1 B 7 VAL B1060 GLN B1062 0 SHEET 2 B 7 GLU B1034 TYR B1039 1 O PHE B1037 N LEU B1061 SHEET 3 B 7 ARG B1008 VAL B1011 1 N ILE B1009 O GLU B1034 SHEET 4 B 7 PHE B1085 HIS B1090 1 N ASP B1086 O ARG B1008 SHEET 5 B 7 LEU B1135 SER B1145 1 N ASN B1136 O PHE B1085 SHEET 6 B 7 ARG B1183 ALA B1189 1 N ARG B1183 O SER B1139 SHEET 7 B 7 VAL B1244 VAL B1247 1 O VAL B1245 N SER B1188 SITE 1 AC1 22 GLY A 13 ALA A 15 SER A 19 ILE A 20 SITE 2 AC1 22 GLN A 40 CYS A 63 ASP A 64 VAL A 65 SITE 3 AC1 22 SER A 91 ILE A 92 GLY A 93 LEU A 144 SITE 4 AC1 22 SER A 145 TYR A 146 LYS A 163 ALA A 189 SITE 5 AC1 22 GLY A 190 PRO A 191 ILE A 192 THR A 194 SITE 6 AC1 22 LEU A 195 HOH A2061 SITE 1 AC2 3 TYR A 146 ALA A 196 PHE A 203 SITE 1 AC3 21 GLY B1013 ALA B1015 SER B1019 ILE B1020 SITE 2 AC3 21 GLN B1040 CYS B1063 ASP B1064 VAL B1065 SITE 3 AC3 21 SER B1091 ILE B1092 LEU B1144 SER B1145 SITE 4 AC3 21 LYS B1163 ALA B1189 GLY B1190 PRO B1191 SITE 5 AC3 21 ILE B1192 THR B1194 LEU B1195 654 B1502 SITE 6 AC3 21 HOH B2060 SITE 1 AC4 2 PHE B1203 NAD B1501 CRYST1 79.580 79.580 323.390 90.00 90.00 120.00 P 61 2 2 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012570 0.007250 0.000000 0.00000 SCALE2 0.000000 0.014510 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003090 0.00000